key: cord-0730079-ruwbyq5c
authors: Sehgal, Pravin B
title: Metastable biomolecular condensates of interferon-inducible antiviral Mx-family GTPases: A paradigm shift in the last three years
date: 2021-07-29
journal: J Biosci
DOI: 10.1007/s12038-021-00187-x
sha: 9a60b49ccf1f4eaf1b1be399abdbda52b982a27c
doc_id: 730079
cord_uid: ruwbyq5c

Membraneless organelles (MLOs) in the cytoplasm and nucleus in the form of phase-separated biomolecular condensates are increasingly viewed as critical in regulating diverse cellular functions. We summarize a paradigm shift over the last 3 years in the field of interferon (IFN)-inducible antiviral Mx-family GTPases. Expression of the ‘myxovirus resistance proteins’ MxA in human cells and its ortholog Mx1 in murine cells is increased 50- to 100-fold by Type I (IFN-α and -β) and III IFNs (IFN-λ). Human MxA forms cytoplasmic structures, while murine Mx1 forms nuclear bodies. Since 2002, it has been widely thought that human (Hu) MxA is associated with the membraneous smooth endoplasmic reticulum (ER). In a paradigm shift, our recent data showed that HuMxA formed membraneless phase-separated biomolecular condensates in the cytoplasm. Some of the HuMxA condensates adhered to intermediate filaments generating a reticular pattern. Murine (Mu) Mx1, which was predominantly nuclear, was also confirmed to be in phase-separated nuclear biomolecular condensates. A subset of Huh7 cells showed association of GFP-MuMx1 with intermediate filaments in the cytoplasm. While cells with cytoplasmic GFP-HuMxA condensates and cytoplasmic GFP-MuMx1 filaments showed an antiviral phenotype towards vesicular stomatitis virus (VSV), those with only nuclear GFP-MuMx1 bodies did not. The new data bring forward the paradigm that both human MxA and murine Mx1 give rise to phase-separated biomolecular condensates, albeit in different subcellular compartments, and that differences in the subcellular localization of condensates of different Mx proteins determines the spectrum of their antiviral activity.

In the process of investigating a phenomenon called 'viral interference' in which one virus interferes with the replication of another related or even unrelated virus, Isaacs and Lindenmann observed in 1957 that chicken embryo tissue in cell culture exposed to live or ultraviolet-irradiated influenza virus type A (FLUAV, an RNA-containing myxovirus isolated from humans) secreted a protein into the culture medium which could render fresh cultures of chicken tissue resistant to a challenge with live FLUAV . This protein, which elicited an antiviral effect against FLUAV, was called 'interferon' (IFN). Subsequently, Lindenmann investigated human-derived FLUAV strain adapted to mice and observed that while the A2G strain of inbred mice, and outbred and field mice were resistant to the production of pulmonary disease when FLUAV was administered by inhalation, other inbred mouse strains (e.g. Balb/c) were susceptible (Lindenmann 1962; Lindenmann et al. 1963) . It was soon recognized that this resistance to inhaled FLUAV was due to a genetic trait dubbed 'Mx' for 'myxovirus resistance gene.' (Lindenmann et al. 1963; Lindenmann 1964; Haller et al. 2015 Haller et al. , 2018 .

Contemporaneously with these studies, numerous investigators examined the ability of one virus to inhibit development of disease by other disparate viruses in animal models (Henle 1950; Ho 1962) . One such investigation, initiated in the early 1960s at the Johns Hopkins School of Public Health and continued at the Virus Research Center, Pune (now called the National Institute of Virology) showed that West Nile virus inoculation of chicken could block the development of sarcoma in the wing web following a challenge with the Rous sarcoma virus (Shirodkar 1965) . Subsequently it was discovered that a vaccine strain of rabies virus was also able to cause this blockade of the Rous sarcoma in chicken (Desai 1970) , and that the plasma/serum of rabies virusinoculated chicken contained a protein which blocked sarcoma development produced by the Rous virus (Desai et al. 1973) . Taken together, an interpretation of these observations was the possibility that virusinduced interferon mediated this anti-tumor effect (Shirodkar 1965; Desai 1970; Desai et al. 1973) . Parenthetically, the present author received his first detailed education about the interferons through participation with Dr. M. V. N. Shirodkar in some of these studies (Desai et al. 1973) .

Evidence for the involvement of interferon (IFN) in vivo in mice resistant to an inhaled challenge of FLUAV was reported in 1979 by Haller and colleagues (as part of the Lindenmann research group) (Haller et al. 1979 ). An antibody that neutralized mouse IFN administered to A2G mice rendered such resistant mice susceptible to development of viral pneumonia. Thus, the 'Mx' resistance gene produced an IFN-inducible gene product with antiviral activity against FLUAV and other myxo-and paramyxoviruses. Over the next two decades, in very elegant studies, Haller and colleagues, identified the mouse Mx1 and as well as human MxA proteins as 60-70 kDa dynamin-family large GTPases which had an antiviral effect against a variety of different RNA-and DNA-containing viruses (table 1; Verhelst et al. 2013; Haller et al. 2015 Haller et al. 2018 . Exposure to cells with appropriate IFN preparations upregulated Mx RNA and protein expression by 50-to 100-fold in human and mouse cells (Haller et al. 2015 (Haller et al. 2018 Yuan and Sehgal 2016) . Moreover, a second human Mx gene ('MxB') was discovered, as was a second mouse Mx gene ('Mx2') (Haller et al. 2015 (Haller et al. , 2018 . Phylogenetic analyses showed that MxA and MxB represented distinct genes, but that murine Mx1 and Mx2 were orthologs of MxA (the rodent ortholog of MxB had been lost) (table 1; Busnadiego et al. 2014; Haller et al. 2015) . Human MxA and MxB, and murine Mx1 and Mx2 proteins had distinct subcellular localizations (cytoplasmic vs. nuclear) and distinct antiviral activities towards different viruses (table 1; see Verhelst et al. 2013; Haller et al. 2015 , Steiner and Pavlovic 2020 for detailed reviews).

Briefly, human MxA formed cytoplasmic structures, human MxB was located in structures near the nuclear pores, murine Mx1 formed nuclear structures, while murine Mx2 was 'granular' and in the cytoplasm. Additionally, human MxA was antiviral towards FLUAV and vesicular stomatitis virus (VSV, a rhabdovirus whose entire life cycle is cytoplasmic), while human MxB was antiviral towards lentiviruses such as HIV but not FLUAV or VSV. In contrast to human MxA, the orthologous nuclear murine Mx1 was antiviral towards FLUAV (which has an obligatory nuclear step in its life cycle) but not against VSV, while, curiously, the cytoplasmic granular murine Mx2 (also an ortholog of human MxA) was antiviral towards VSV (Haller et al. 2015; Sehgal et al. 2020b) (table 1). The GTPase activity was required for these antiviral activities (Dick et al. 2015; Nigg and Pavlovic 2015; Haller et al. 2015 Haller et al. , 2018 . However, despite extensive studies over the last six decades, the molecular mechanisms by which Mx proteins inhibit replication of different viruses in intact cells are incompletely understood (Haller et al. 2015 (Haller et al. , 2018 Sehgal et al. 2020b; Steiner and Pavlovic 2020) . Surprisingly, even the understanding of the basic cell biology of Mx proteins needed a paradigm shift in the last three years.

In 2002 the Haller group reported that electron microscopy of cells transfected with human MxA expression vector together with infection by La Crosse virus revealed juxtanuclear membraneless structures which contained the viral nucleocapsid (N) protein and MxA. In this article in 2002, Haller and colleagues stated specifically that these structures did not associate with any intracellular membranes .

In contrast, also in 2002, McNevin and colleagues (Accola et al. 2002) claimed that MxA expressed in Hela and Hep3B cells was associated with the smooth endoplasmic reticulum (ER). However, in the article itself, these authors admitted that they were unable to associate MxA with any customary markers for the ER or any other membrane-bound organelles, and that the association was 'presumed' to be with the ER because of an impression that MxA colocalized with the 'autocrine motility factor receptor' (AMF), which they claimed had been assigned by them to the ER. Nevertheless, the abstract dropped the 'presumably' and the title of Accola et al. (2002) stated categorically that MxA was associated with the smooth ER.

In 2006, Haller and colleagues (Stertz et al. 2006) appear to have adjusted their earlier inference from 2002 that MxA structures were membraneless (as in Kochs et al. 2002) and now claimed that MxA associated with a 'distinct subcompartment of the smooth endoplasmic reticulum' in the cells they now investigated (the Huh7 human hepatoma cell line) (Stertz et al. 2006) . Experimentally, Stertz et al. (2006) showed images of Huh7 cells with a cytoplasmic resticular meshwork distribution of HA-MxA. The customary markers for ER were of no avail, but an inhouse antibody towards syntaxin 17 was presented as a marker of the ER (see figure 3 below for the correct answer: that meshwork in Huh7 cells is of HA-MxA condensates adhering to intermediate filaments; Davis et al. 2019; Sehgal et al. 2020a) .

The two articles - Accola et al. (2002) and Stertz et al. (2006) -have had a strong grip on the MxA field despite the inconclusive data presented. Hundreds of citations have referred to these two articles as evidence that MxA associates with smooth endoplasmic reticulum. Even the Kochs et al. (2002) article which showed 'membraneless' structures of MxA is repetitively misquoted in the Mx literature as having shown that MxA associates with the ER (see Sadler and Williams 2011 for one example).

Against this cumulative backdrop in the MxA field over the last 15 years, the author's lab stumbled on to observations that did not fit with the ER localization of MxA (Yuan and Sehgal 2016). Figure 1A shows examples of variably shaped and sized mesoscale structures in the cytoplasm of HEK293T cells expressing HA-MxA (using the expression construct provided by Stertz et al. 2006) . Figure 1B shows that at higher magnification the HA-MxA structures were clearly distinct from the reticulon-4-containing endoplasmic reticulum (Yuan and Sehgal 2016; Davis et al. 2019) . Numerous additional studies in the author's lab showed the divergence of MxA structures from the ER (summarized in Davis, et al. 2018; . Thus, by the fall of 2016, we had concluded that there was little convincing experimental evidence that MxA associated with the ER. However, the paradigm in the field that 'MxA associates with the ER' based on Accola et al. (2002) and Stertz et al. (2006) , was overwhelmingly and vigorously espoused (especially by numerous reviewers).

The This paradigm shift has led us forward along two paths -the first to address questions about the condensate nature of human MxA structures in the cytoplasm and murine Mx1 structures in the nucleus (table 1) , and the second to conduct extensive data mining of the Mx literature as part of the process of reinterpreting previous observations. As one example, we now infer that the membraneless human MxB structures juxtaposed to nuclear pores observed in 2004 by King et al. by electron microscopy also likely represent biomolecular condensates (table 1). Clearly at this time, there are many unanswered questions. The reader is referred to previous detailed reviews on the biology of Mx proteins in the context of innate immunity (Haller et al. 2015 (Haller et al. 2018 . At this time, it would be premature for us tie aspects of the cell biology of Mx condensates (assembly/disassembly and metastability) to the broader biology of Mx proteins (antiviral activity against different viruses). Also, at this time, we are unaware of the identification of other dynamin-family large GTPases or other IFN-induced proteins that form biomolecular condensates (we are sure that these will come to be identified soon). The focus of this overview is to provide an interim summary of our data which helped identify cytoplasmic MxA and nuclear Mx1 structures as biomolecular condensates. It should be apparent from this Introduction that we are the only research group in the Mx field that has moved in this direction at this time.

As a general comment, in addition to various membrane-bound subcellular compartments, the eukaryotic cell contains organized membraneless biomolecular condensates of proteins and nucleic acids which form functional organelles (Mitrea and Kriwacki 2016; Banani et al. 2017; Shin and Brangwynne 2017; Alberti 2017; Gomes and Shorter 2019; Alberti et al. 2019; Sehgal et al. 2020a) . Examples include the nucleolus, the nucleoporin granules, nuclear speckles and paraspeckles, nuclear promyelocytic leukemia (PML) bodies, nuclear Cajal bodies, cytoplasmic processing (P) bodies, germinal P bodies, Balbiani bodies, Negri bodies, stress granules, translation promoting TPA-inducible sequence 11b (TIS) granules, cytoplasmic and nuclear viral replication and maturation complexes, and several more recent discoveries such as condensates of synapsin, of the DNA sensor protein cyclic GMP-AMP synthase (cGAS) in the cytoplasm, the cytoplasmic antiviral proteins human MxA, the nuclear antiviral protein murine Mx1, and active transcription-and splicing-associated condensates in the nucleus. Overall, these condensates have liquid-like internal properties and alter shape and consistency (are 'metastable') changing from liquid-like to a gel and/or to filaments and even undergo disassembly/reassembly To clarify the nomenclature of the Mx protein family we adopt the gene lineage tracing presented by Busnadiego et al. (2014) and Haller et al. (2015) as follows: most mammalian Mx proteins are formed from two distinct gene lineages (MxA or MxB) that arose from an ancient duplication event. Thus, humans have two Mx proteins -MxA and MxB (some investigators call these as human Mx1 and human Mx2 respectively although the terms Mx1 and Mx2 are correctly reserved for murine Mx proteins). Although mice also have two Mx genes -Mx1 and Mx2, both these are paralogous members of the human MxA lineage. Thus, human MxB (which is also called human Mx2 by some investigators) and murine Mx2 are not orthologous. We use the terms MxA or HuMxA for the human protein, and Mx1 or MuMx1 for the orthologous murine protein. Parenthetically, rats have three Mx proteins Mx1, Mx2 and Mx3 (Haller et al. 2015) . Rat Mx1 and rat Mx2 are orthologs of human MxA, have antiviral activity and form nuclear and cytoplasmic granules respectively, while rat Mx3 is diffuse in the cytoplasm and lacks antiviral activity.

Human MxA forms cytoplasmic structures while murine Mx1 mainly forms nuclear bodies (table 1; . The molecular mechanisms of the Mx antiviral effects are incompletely understood; these effects include inhibition of early and late viral transcription and viral replication, as well as effects at the level of the transit of viral components through the nuclear pore Verhelst et al. 2013; Haller et al. 2015; Steiner and Pavlovic 2020) . It is only in the last 3 years that we recognized that human MxA formed metastable membraneless biomolecular condensates in the intact-cell cytoplasm, and only in the last year that murine Mx1 formed biomolecular condensates mainly in the nucleus, but also in the cytoplasm in some cells (figure 6; reviewed in Sehgal et al. 2020a, b) . Both the cytoplasmic HuMxA bodies and nuclear MuMx1 bodies comprised phase-separated membraneless organelles (MLOs) with a gel-like internal consistency (as tested using fluorescence recovery after photobleaching (FRAP) methods) (Davis et al. 2019; Sehgal et al. 2020a, b) . Additionally, HuMxB forms cytoplasmic membraneless structures juxtaposed to the cytoplasmic side of nuclear pores (Table 1) (King et al. 2004; Goujon et al. 2013; reviewed in Sehgal et al. 2020b; Steiner and Pavlovic 2020) .

Remarkably, it is also now recognized that replication/maturation of many viruses also involves phaseseparated liquid droplets [e.g. vesicular stomatitis (VSV), rabies (Negri bodies), influenza A, Ebola, measles, Epstein-Barr, and even SARS-CoV-2 viruses] (reviewed in Sehgal et al. 2020a, b) . It is noteworthy that MxA cytoplasmic condensates in virus infected cells incorporate respective viral nucleocapsid proteins (table 1) Davis et al. 2019; reviewed in Sehgal et al. 2020a, b) . Overall, human MxA forms disparate membraneless structures solely in the cytoplasm and has antiviral activity towards several RNA-and DNA-containing viruses including orthomyxo-and rhabdoviruses (Haller et al. 2015; Sehgal et al. 2020a, b) . Human MxB is mainly associated with the cytoplasmic side of nuclear pores (through an N-terminal nuclear localization signal, NLS) and additional cytoplasmic membraneless structures. Full-length MxB has antiviral activity against HIV and other lentiviruses, and herpesviruses by blocking entry of viral components into the nucleus, but not against influenza A virus (FLUAV) (King et al. 2004; Goujon et al. 2013; reviewed in Haller et al. 2015 and in Steiner and Pavlovic 2020) . However, ectopic expression of genetically modified MxB targeting it to the cytoplasm (using the N-terminal 43 amino acid segment from MxA) or nucleus (using the T-antigen NLS) renders MxB antiviral towards FLUAV (Steiner and Pavlovic 2020) .

Murine Mx1 is mainly in nuclear bodies (it has a 'weak' C-terminal NLS, Zürcher et al. 1992a, b, c) , while murine Mx2 is mainly in cytoplasmic structures (Zürcher et al. 1992c; Haller et al. 2015) . In terms of antiviral activity, the nuclear murine Mx1 has antiviral activity towards influenza virus (FLUAV) (which has an obligate nuclear transcription step) but not vesicular stomatitis virus (VSV) (replicates entirely in the cytoplasm), while the cytoplasmic granular murine Mx2 has antiviral activity towards VSV but not FLUAV (Haller et al. 2015 ; table 1). Curiously, the nuclear-predominant rat Mx1 has antiviral activity towards both FLUAV and VSV, while the cytoplasmic-predominant rat Mx2 is antiviral towards VSV only (Verhelst et al. 2013; Haller et al. 2015) . Rat Mx3, which is mainly dispersed in the cytoplasm, has little apparent antiviral activity (Verhelst et al. 2013; Haller et al. 2015) . Although murine Mx1 artificially deleted of its C-terminal NLS is cytoplasmic it remains inactive against VSV (Zürcher et al. 1992a (Zürcher et al. , 1992b . In contrast, wild-type GFP-MuMx1 expressed in human hepatoma Huh7 cells associates with cytoplasmic intermediate filaments and now shows antiviral activity against VSV (Sehgal et al. 2020b , table 1 and figures 7 and 8 below). Thus, the different subcellular localizations of MLOs of different Mx proteins contribute to their respective antiviral activities. Our overall focus is to understand the formation, dynamics and function of different antiviral Mx biomolecular condensates. The objective is to move the field of antiviral Mx proteins into the realm of phaseseparated membraneless organelles (MLOs) and biomolecular condensates, and set the stage for detailed proteomics studies in the future of the composition of Mx condensates.

Cytoplasmic human MxA condensates and nuclear murine Mx1 condensates (figure 6) comprised dramatically metastable (shape-changing) phase-separated table 1 ). These GFP-MxA and GFP-Mx1 condensates were disassembled by 1,6-hexanediol (and were thus liquid-like phase separated structures) (Davis et al. 2019) . Disassembly of nuclear GFP-Mx1 bodies by hexanediol was than that of cytoplasmic GFP-MxA bodies (Sehgal et al. 2020b ). Both cytoplasmic GFP-MxA and nuclear GFP-Mx1 condensates showed a gellike internal consistency in FRAP assays with approximately 18-20% internal mobility) (Davis et al. 2019; Sehgal et al. 2020b ). Importantly, IFN-a-induced endogenous MxA in human cells also formed cytoplasmic condensates (Davis et al. 2018 (Davis et al. 2019 Sehgal et al. 2020a) .

As another aspect of their metastability, both cytoplasmic GFP-MxA condensates and nuclear GFP-Mx1 condensates were disassembled by exposing cells to hypotonic buffer (ELB), and then reassembled upon shifting cells to isotonic buffer (figure 4; Davis et al. 2019; Sehgal et al. 2020b ). This hypotonicity-driven disassembly/metastability is reminiscent of conditions of cells with intracellular edema. This metastability was also observed for GFP-Mx1 nuclear condensates in homologous murine cells (NIH 3T3) (Sehgal et al. 2020b) . We interpret hypotonic disassembly/isotonic reassembly as resulting from rapid cytoplasmic uncrowding and recrowding mechanisms (i.e. responsive to cytoplasmic swelling and its reversal) (Davis et al. 2019; Sehgal et al. 2020a, b) .

Live-cell imaging confirmed that spherical cytoplasmic MxA condensates underwent homotypic fusion (Davis et al. 2019) . There was further metastability in terms of a spherical to filamentous change when cells were exposed to physical compression and/ or hypoxia (by placement on a coverslip on live cells), nitric oxide scavenging (by c-PTIO) or inhibition of GTPase activity (by dynasore) (Davis et al. 2019 ). The unanswered question at the moment is whether these changes influence antiviral activity.

As with stress granules (Ditlev et al. 2018; Shiina 2019) , there is structural heterogeneity in cytoplasmic MxA condensates, especially the presence of a detergent (saponin) resistant core in some condensates (Davis et al. 2019) . MxA condensates disassembled upon saponin permeabilization of the plasma membrane of cells consistent with an 'uncrowding' mechanism regulating MxA condensate structure. Additionally, 20-30% of cells retained saponin- resistant 'cores' of GFP-MxA condensates (Davis et al. 2019) . Thus, in future studies, we shall follow the paradigm established in studies of stress granule components (Banani et al. 2017; Ditlev et al. 2018; Alberti et al. 2019; Shiina 2019) , by first identifying components of MxA condensate cores, before exploring the more transient association of other client proteins with these structures.

While human GFP-MxA structures were exclusively cytoplasmic, and murine GFP-Mx1 structures mainly nuclear (as in figure 6 ), a subset of cells (in human Huh7 and murine NIH3T3 cell lines) transiently expressing MuGFP-Mx1 showed accumulation of this protein in cytoplasmic bodies and filaments (figure 7) (Sehgal et al. 2020b) . This formation of cytoplasmic GFP-Mx1 structures was not a consequence of overexpression of the recombinant protein but occurred even when there was only low level of expression of GFP-Mx1 (Sehgal et al. 2020b) . In Huh7 cells, these cytoplasmic filaments of GFP-Mx1 consisted of vimentin-positive intermediate filaments (Sehgal et al. 2020b) . The possibility that, in contrast to GFP-HuMxA structures which lie adjacent to intermediate filaments ( This heterogeneity of subcellular location of MuGFP-Mx1 condensates was reflected in differences in antiviral properties (Sehgal et al. 2020b) . Using single-cell-based assays for antiviral activity towards VSV, on the one hand we were able to confirm that cytoplasmic human MxA was antiviral towards VSV, but that nuclear murine Mx1 was not (figure 8). On the other hand, cells exhibiting cytoplasmic filamentous wild-type MuGFP-Mx1 had an antiviral effect against VSV (figure 8). These data emphasize the occurrence of a broader antiviral spectrum of Mx proteins in different cell types based upon the subcellular cytoplasmic compartment in which the respective Mx proteins form condensates (Haller et al. 2015; Sehgal et al. 2020b ; also see Steiner and Pavlovic 2020 for MxB).

Overall, our new data show that (a) both human MxA and murine Mx1 give rise to metastable phase-separated biomolecular condensates, albeit in different subcellular compartments (cytoplasm vs. nucleus respectively), (b) when in the cytoplasm, both human MxA and murine Mx1 can associate with intermediate filaments, and (c) both human MxA and murine Mx1 when cytoplasmic exhibit an antiviral activity towards VSV -a rhabdovirus which replicates and matures entirely in the cytoplasm (table 1). The data showing the close relationship between membraneless MxB structures and nucleoporins on the cytoplasmic face of nuclear pores and the involvement of MxB in regulating cargo transit through the pore channel (King Two days later the cultures were fixed using 4% paraformaldehyde, permeabilized using the 0.05% Triton buffer, and stained with DAPI to visualize the nuclei, and imaged using two-color fluorescence. Approximately 20-30% of transfected cells showed cytoplasmic murine GFP-Mx1 as shown in Panels A, B and C. Panel A shows two adjacent cells -one showing GFP-Mx1 exclusively in nuclear bodies and one cell with GFP-Mx1 present extensively in cytoplasmic filaments and cytoplasmic structures. Panel B shows adjacent cells -one with extensive cytoplasmic filaments and cytoplasmic bodies (arrows) of GFP-Mx1 and the other showing a nucleus with only nuclear GFP-Mx1 bodies (at lower edge). Panel C shows a cell with both nuclear GFP-Mx1 bodies and cytoplasmic filaments. Modified from Sehgal et al. (2020b Sehgal et al. ( ). et al. 2004 Goujon et al. 2013; reviewed in Steiner and Pavlovic 2020) allow us to now suggest that MxB structures at and near nuclear pores also represent phase-separated biomolecular condensates (table 1; Sehgal et al. 2020b ).

Murine Mx1 typically shows antiviral activity towards influenza A virus (FLUAV) and other orthomyxoviruses which require a nuclear step in their replication, but not towards rhabdoviruses such as VSV which replicate entirely in the cytoplasm (Verhelst et al. 2013; Haller et al. 2015) (table 1) . In contrast, functional murine Mx2 (isolated from feral mice) was observed to display an antiviral activity towards VSV but not FLUAV (Verhelst et al. 2013; Haller et al. 2015) . Commensurately, while murine Mx1 was observed to be in nuclear bodies, murine Mx2 was observed to be mainly in granular cytoplasmic structures (Haller et al. 2015) , which might perhaps also represent biomolecular condensates (table 1) . Moreover, we observed that a subset of cells expressing murine GFP-Mx1 express this protein in cytoplasmic bodies and filaments. Using single-cellbased assays for VSV replication we discovered that cells that expressed cytoplasmic wild-type GFP-Mx1, but not those exhibiting only nuclear GFP-Mx1 condensates, displayed an antiviral effect against this virus -a virus which replicates solely in the cytoplasm.

Mutational studies of human MxA show that the GTPase activity is required for most of its antiviral b Figure 8 . Differences in subcellular localization of MuGFP-Mx1 condesnates (in cytoplasm vs. nucleus) affects antiviral activity towards VSV. Huh7 cells (approx. 2 9 10 5 ) per 35 mm plate, transfected with the GFP-HuMxA (as a positive control) or GFP-MuMx1 expression vectors 2 days earlier, were replenished with 0.25 ml serum-free Eagle's medium and then 20 ll of a concentrated VSV stock of the wt Orsay strain added (corresponding to multiplicity of infection [10 plaque forming units/cell). The plates were rocked every 15 min for 1 hr followed by addition of 1 ml of full culture medium. The cultures were fixed with 4% paraformaldehyde at 4 hr after the start of the VSV infection and the extent of VSV N protein expression in individual cells evaluated using immunofluorescence methods (using the mouse anti-N mAb) and Image J for quantitation. Panels activity (except that against hepatitis B virus) (Haller et al. 2015; Dick et al. 2015; Nigg and Pavlovic 2015; Steiner and Pavlovic 2020) . Data in the literature also reveal that MxA mutants lacking GTPase activity can still form cytoplasmic condensates (Dick et al. 2015; Nigg and Pavlovic 2015) . Mutations that cause dispersal of MxA in the cytoplasm (e.g. the D250N mutant) lacked antiviral activity (Dick et al. 2015; Steiner and Pavlovic 2020) . The R645 point mutant of MxA, which was in larger cytoplasmic granules, had the unusual property of inhibiting FLUAV but not VSV, even though the wt MxA showed antiviral activity towards both viruses (Zürcher et al. 1992b) . A mutational analysis of rat Mx2 showed that mutants that formed 'granular' cytoplasmic structures exhibited antiviral activity towards VSV, while those that were 'diffuse' in the cytoplasm did not (Zürcher et al. 1992c) . These data suggest that condensate formation may be important but not sufficient for the antiviral activity of Mx proteins. The hypotonicity-driven disassembly of Mx protein condensates in live cells (figure 4; Davis et al. 2019; Sehgal et al. 2020b) highlight an unusual aspect of Mx protein chemistry. The biochemical basis for this hypotonicity driven disassembly may reflect the effect of cytoplasmic 'crowding' on higher-order protein structure or rapid changes due to hypotonicity-triggered post-translational modifications.

At this time there are many unanswered questions related to the biochemical mechanisms involved in the formation and metastability of Mx condensates in the cell cytoplasm and the nucleus. The structural contributions of intrinsically disordered domains (IDRs) in Mx proteins (the L4 loop and the N-terminal region; figure 5) to condensate formation remain to be investigated. The relationship between condensate formation and antiviral activities remains unclear. Nevertheless, it is already clear that subcellular localization of Mx condensates is an important determinant of antiviral specificity. The key paradigm shift in the last three years has been to move the Mx field away from the widely prevalent interpretation that MxA associates with intracellular membranes (e.g. the endoplasmic reticulum) towards consideration of Mx structures as membraneless organelles (MLOs).

The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum

The wisdom of crowds: regulating cell function through condensed states of living matter

Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates

Biomolecular condensates: organizers of cellular biochemistry

Spontaneous driving forces give rise to protein-RNA condensates with coexisting phases and complex material properties

Amyloid-like self-assembly of a cellular compartment

Host and viral determinants of Mx2 antiretroviral activity

Interferon-alpha-induced cytoplasmic MxA structures in hepatoma Huh7 and primary endothelial cells

Human antiviral protein MxA forms novel metastable membraneless cytoplasmic condensates exhibiting rapid reversible tonicity-driven phase transitions

2018 mTORC1 Controls phase separation and the biophysical properties of the cytoplasm by tuning crowding

Sarcoma blockade in vivo: rabies-Rous system in chickens

A rabies-induced serum factor inhibiting Rous sarcoma virus in chickens

Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity

Who's in and who's out -compositional control of biomolecular condensates

DNA-induced liquid phase condensation of cGAS activates innate immune signaling

Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukemia protein nuclear bodies

The molecular language of membraneless organelles

Human Mx2 is an interferon-induced post-entry inhibitor of HIV-1 infection

Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity

Genetically determined, interferon-dependent resistance to influenza virus in mice

Interferon-induced Mx proteins in antiviral host defense

Mx GTPases: dynamin-like antiviral machines of innate immunity

The discovery of the antiviral resistance gene Mx: a story of great ideas, great failures, and some success

Interference phenomena between animal viruses: a review

Virus interference. I. The interferon

Virus interference. II. Some properties of interferon

Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB

Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes

Resistance of mice to mouse-adapted influenza A virus

Inheritance of resistance to influenza virus in mice

The resistance of A2G mice to myxoviruses

A membraneless organelle associated with the endoplasmic reticulum enables 3' UTR-mediated protein-protein interactions

A liquid phase of synapsin and lipid vesicles

Phase separation in biology, functional organization of a higher order

Oligomerization and GTPbinding Requirements of MxA for viral target recognition and antiviral activity against Influenza A Virus

Kinasecontrolled phase transition of membraneless organelles in mitosis

Coactivator condensation at super-enhancers links phase separation and gene control. Science Sadler AJ and Williams B 2011 Dynamiting viruses with MxA

Biomolecular condensates in cancer cell biology: interleukin-6-induced cytoplasmic and nuclear STAT3/PY-STAT3 condensates in hepatoma cells. Contemp

Biomolecular condensates in cell biology and virology: phase-separated membraneless organelles (MLOs)

Mx1 forms phase-separated nuclear condensates and associates with cytoplasmic intermediate filaments: novel antiviral activity against vesicular stomatitis virus

Liquid-and solid-like RNA granules form through specific scaffold proteins and combine into biphasic granules

Liquid phase condensation in cell physiology and disease

The blocking effect of West Nile virus on production of sarcoma by Rous virus in chickens

Subcellular localization of MxB determines its antiviral potential against influenza virus

Interferoninduced, antiviral human MxA protein localizes to a distinct subcompartent of the smooth endoplasmic reticulum

Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiol

This work was supported by a grant from the New York Medical College, and by personal funds of PBS.